Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.

Persu A, Devuyst O, Lannoy N, Materne R, Brosnahan G, Gabow PA, Pirson Y, Verellen-Dumoulin C.

J Am Soc Nephrol. 2000 Dec;11(12):2285-96.

2.

Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.

O'Sullivan DA, Torres VE, Gabow PA, Thibodeau SN, King BF, Bergstralh EJ.

Am J Kidney Dis. 1998 Dec;32(6):976-83.

PMID:
9856513
3.

Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.

Xu N, Glockner JF, Rossetti S, Babovich-Vuksanovic D, Harris PC, Torres VE.

J Nephrol. 2006 Jul-Aug;19(4):529-34.

PMID:
17048214
4.

Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth.

Li H, Yang W, Mendes F, Amaral MD, Sheppard DN.

Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1176-86. doi: 10.1152/ajprenal.00130.2012. Epub 2012 Aug 8.

5.

Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.

Ashavaid TF, Kondkar AA, Dherai AJ, Raghavan R, Udani SV, Udwadia ZF, Desai D.

Mol Diagn. 2005;9(2):59-66.

PMID:
16137181
6.

Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.

Gallegos-Orozco JF, E Yurk C, Wang N, Rakela J, Charlton MR, Cutting GR, Balan V.

Am J Gastroenterol. 2005 Apr;100(4):874-8.

PMID:
15784035
7.

Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.

Oglesby IK, Chotirmall SH, McElvaney NG, Greene CM.

J Immunol. 2013 Apr 1;190(7):3354-62. doi: 10.4049/jimmunol.1202960. Epub 2013 Feb 22.

8.

Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.

Duguépéroux I, De Braekeleer M; Participating Centres to the French National Cystic Fibrosis Registry..

J Cyst Fibros. 2004 Dec;3(4):259-63.

11.

Genotype and phenotype in cystic fibrosis.

Zielenski J.

Respiration. 2000;67(2):117-33. Review.

PMID:
10773783
13.

Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.

Snodgrass SM, Cihil KM, Cornuet PK, Myerburg MM, Swiatecka-Urban A.

PLoS One. 2013 May 9;8(5):e63167. doi: 10.1371/journal.pone.0063167. Print 2013.

14.

CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis.

Hirtz S, Gonska T, Seydewitz HH, Thomas J, Greiner P, Kuehr J, Brandis M, Eichler I, Rocha H, Lopes AI, Barreto C, Ramalho A, Amaral MD, Kunzelmann K, Mall M.

Gastroenterology. 2004 Oct;127(4):1085-95.

PMID:
15480987
15.

Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.

Stanton BA.

Wien Klin Wochenschr. 1997 Jun 27;109(12-13):457-64. Review.

PMID:
9261986
16.

The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.

Mall M, Kreda SM, Mengos A, Jensen TJ, Hirtz S, Seydewitz HH, Yankaskas J, Kunzelmann K, Riordan JR, Boucher RC.

Gastroenterology. 2004 Jan;126(1):32-41.

PMID:
14699484
17.

Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.

Mutesa L, Azad AK, Verhaeghe C, Segers K, Vanbellinghen JF, Ngendahayo L, Rusingiza EK, Mutwa PR, Rulisa S, Koulischer L, Cassiman JJ, Cuppens H, Bours V.

Chest. 2009 May;135(5):1233-42. doi: 10.1378/chest.08-2246. Epub 2008 Nov 18.

18.
19.

Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.

Siryani I, Jama M, Rumman N, Marzouqa H, Kannan M, Lyon E, Hindiyeh M.

PLoS One. 2015 Jul 24;10(7):e0133890. doi: 10.1371/journal.pone.0133890. eCollection 2015.

20.

Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.

Bienvenu T, Sermet-Gaudelus I, Burgel PR, Hubert D, Crestani B, Bassinet L, Dusser D, Fajac I.

Am J Respir Crit Care Med. 2010 May 15;181(10):1078-84. doi: 10.1164/rccm.200909-1434OC. Epub 2010 Feb 18.

PMID:
20167849

Supplemental Content

Support Center